Detalhe da pesquisa
1.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
N Engl J Med
; 388(8): 719-732, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795891
2.
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
BMC Urol
; 22(1): 71, 2022 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488333
3.
Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.
BMC Cancer
; 20(1): 215, 2020 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171277
4.
A cohort profile of the Graham Roberts study cohort.
Front Oncol
; 13: 1334183, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264755
5.
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Eur Urol
; 84(3): 321-330, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277275
6.
The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancer.
Br Dent J
; 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145242
7.
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study
Cancers (Basel)
; 14(24)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551542
8.
Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study.
Eur Urol
; 77(3): 380-387, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31594705
9.
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study.
ESMO Open
; 3(5): e000397, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30116592
10.
Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.
Clin Genitourin Cancer
; 16(3): 240-244, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336917